- Home
- CVKD vs ATER Comparison
CVKD vs ATER Comparison
Compare CVKD & ATER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVKD
- ATER
- Stock Information
- Founded
- CVKD 2022
- ATER 2014
- Country
- CVKD United States
- ATER United States
- Employees
- CVKD N/A
- ATER N/A
- Industry
- CVKD Medicinal Chemicals and Botanical Products
- ATER Home Furnishings
- Sector
- CVKD Health Care
- ATER Consumer Discretionary
- Exchange
- CVKD Nasdaq
- ATER Nasdaq
- Market Cap
- CVKD 20.8M
- ATER 22.8M
- IPO Year
- CVKD 2023
- ATER N/A
- Fundamental
- Price
- CVKD $16.17
- ATER $2.24
- Analyst Decision
- CVKD Strong Buy
- ATER Strong Buy
- Analyst Count
- CVKD 2
- ATER 1
- Target Price
- CVKD $46.00
- ATER N/A
- AVG Volume (30 Days)
- CVKD 79.1K
- ATER 58.4K
- Earning Date
- CVKD 11-07-2024
- ATER 11-11-2024
- Dividend Yield
- CVKD N/A
- ATER N/A
- EPS Growth
- CVKD N/A
- ATER N/A
- EPS
- CVKD N/A
- ATER N/A
- Revenue
- CVKD N/A
- ATER $107,193,000.00
- Revenue This Year
- CVKD N/A
- ATER N/A
- Revenue Next Year
- CVKD N/A
- ATER $5.47
- P/E Ratio
- CVKD N/A
- ATER N/A
- Revenue Growth
- CVKD N/A
- ATER N/A
- 52 Week Low
- CVKD $5.40
- ATER $0.23
- 52 Week High
- CVKD $32.55
- ATER $3.95
- Technical
- Relative Strength Index (RSI)
- CVKD 61.78
- ATER 32.99
- Support Level
- CVKD $10.65
- ATER $2.33
- Resistance Level
- CVKD $12.25
- ATER $2.39
- Average True Range (ATR)
- CVKD 1.68
- ATER 0.16
- MACD
- CVKD 0.32
- ATER -0.02
- Stochastic Oscillator
- CVKD 76.54
- ATER 13.25
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.
About ATER Aterian Inc.
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operated brands including Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.